Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxybutynin for Hyperhidrosis
NCT01855256Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Jun 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxybutynin in hyperhidrosis, sponsored by Centre Hospitalier Universitaire de Brest. Started Jun 2013; status: completed.
02
Drugs
oxybutynin
03
Conditions
hyperhidrosis
Beyond the preview
Go deeper on NCT01855256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01855256.